Genomic analysis of prostate cancer unveiledJune 26th, 2010 - 4:11 pm ICT by ANI
Washington, June 26 (ANI): Scientists have assembled the most comprehensive genomic analysis of prostate cancer to date.
The hope is that the database will result in new drug targets and the development of clinically meaningful patient subgroups to help tailor individual treatment decisions.
“One of the holy grails of prostate cancer is to identify which tumors need to be aggressively treated and which don’t. Ultimately, what we have learned could lead to the creation of a genetic-based test to determine which prostate cancers might become more virulent and require aggressive treatment and which tumors may not,” said senior study author Charles Sawyers, from Memorial Sloan-Kettering Cancer Center (MSKCC).
The difference between aggressive treatment and a “wait and watch” approach has obvious quality-of-life implications for prostate cancer patients.
The MSKCC team used an integrated, comprehensive approach to analyze 218 primary and metastatic samples and 12 cell lines. All samples were procured from patients treated by radical prostatectomy at MSKCC.
The analysis revealed a much higher frequency of alterations in the androgen receptor pathway than previously suspected. Also, the pattern of DNA copy number alterations identified defined subsets of low-and high-risk disease beyond what is revealed by Gleason score.
The study has been published early online on June 24 in the journal Cancer Cell. (ANI)
- Surgery effective for aggressive prostate cancer patients - Sep 28, 2010
- New tool opens alternate door to prostate cancer diagnosis - Apr 03, 2011
- Gene fusion is the 'smoking gun' in the development of prostate cancer: Study - May 19, 2010
- Molecular predictor of metastatic prostate cancer identified - Feb 03, 2011
- Biomarkers for particularly aggressive prostate cancers discovered - Jul 13, 2010
- Genetic change helps lung tumors spread to other parts of the body - Apr 07, 2011
- Experimental drug for advanced prostate cancer shows promise - Apr 15, 2010
- New prostate cancer imaging technique can 'see' tumors grow - Dec 03, 2010
- What prompts lung cancer to spread - Jul 03, 2009
- Drug for rare childhood cancer may help prevent prostate cancer spread - Apr 30, 2011
- Potential driver of some aggressive prostate cancers found - Apr 05, 2011
- How genetic changes make some brain cancers more aggressive - Oct 02, 2010
- Novel technology helps in prostate cancer treatment - May 13, 2010
- Molecule discovery good news for prostate cancer sufferers - Dec 29, 2009
- Full genetic blueprint of multiple prostate tumors unveiled - Feb 10, 2011
Tags: aggressive treatment, androgen receptor, cancer cell, charles sawyers, dna copy, drug targets, gleason score, holy grails, journal cancer, kettering cancer center, memorial sloan kettering, memorial sloan kettering cancer center, prostate cancer, prostate cancer patients, prostate cancers, radical prostatectomy, risk disease, sloan kettering cancer, sloan kettering cancer center, treatment decisions